23 Feb LogicBio Therapeutics
Fred Chereau, CEO
April 20 | 3:00pm | Gaudi 2 Ballroom
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood. The company’s genome editing platform, GeneRide™, is a new approach to precise gene insertion harnessing a cell’s natural DNA repair process potentially leading to durable therapeutic protein expression levels. The company’s gene delivery platform, sAAVy™, is an adeno-associated virus capsid engineering platform designed to optimize gene delivery for treatments in a broad range of indications and tissues.